Clinical trials
Pregnancy Complications trials in Israel
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 1 |
| 2012 | 2 |
| 2015 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 8 |
| Completed | 2 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tel-Aviv Sourasky Medical Center | 3 |
| Ariella Shitrit | 1 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1 |
| HaEmek Medical Center, Israel | 1 |
| Hillel Yaffe Medical Center | 1 |
| Rambam Health Care Campus | 1 |
| Sheba Medical Center | 1 |
| Soroka University Medical Center | 1 |
| University Hospital, Basel, Switzerland | 1 |
| Wolfson Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pregnancy Complications | 12 |
| Pre-Eclampsia | 2 |
| Abruptio Placentae | 1 |
| Anxiety Disorders | 1 |
| Congenital Abnormalities | 1 |
| Diabetes Mellitus | 1 |
| Fetal Growth Retardation | 1 |
| Hemorrhagic Stroke | 1 |
| Hyperglycemia | 1 |
| Ischemic Stroke | 1 |
Trials
Showing 76 to 12 of 12. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.